Методы исследования кардиотоксичности высокодозной химиотерапии с аутологичной трансплантацией костного мозга при гемобластозах

Автор: Саржевский В.О., Мельниченко В.Я., Вахромеева М.Н., Колесникова Д.С.

Журнал: Вестник Национального медико-хирургического центра им. Н.И. Пирогова @vestnik-pirogov-center

Статья в выпуске: 4 т.8, 2013 года.

Бесплатный доступ

В обзоре представлены современные данные, касающиеся методов исследования кардиотоксичности высокодозной химиотерапии с аутологичной трансплантацией костного мозга (периферических стволовых клеток) у больных гемобластозами. Освещены перспективные направления оптимизации подходов оценки кардиологических осложнений у данной категории больных.

Кардиотоксичность, высокодозная химиотерапия, аутологичная трансплантация костного мозга

Короткий адрес: https://sciup.org/140188265

IDR: 140188265

Список литературы Методы исследования кардиотоксичности высокодозной химиотерапии с аутологичной трансплантацией костного мозга при гемобластозах

Кардиология. Национальное руководство: краткое издание/под ред. Ю.Н. Беленкова, Р.Г. Оганова. -М.: ГЭОТАР-Медиа, 2012. -864 с.
Минимальные клинические рекомендации Европейского общества медицинской онкологии (ESMO), М.-2010, стр. 428.
Шкляева А.В. Ультразвуковая оценка функционального состояния левого желудочка сердца при высокодозной немиелоаблативной химиотерапии у больных злокачественными лимфомами: автореф. дис. канд. мед. наук/А. В. Шкляева. -Обнинск, 2011.
Appelbaum F.R., Sullivan K.M., Buckner C.D. et al. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation//J Clin Oncol. 1987 Sep; 5(9):1340-7.
Auner H.W., Tinchon C., Linkesch W. et al. Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies//Ann Hematol. 2003 Apr; 82(4): 218-22. Epub 2003 Mar 25.
Bosch X., Esteve J., Sitges M. et al. Prevention of chemotherapy-induced left ventricular dysfunction with enalapril and carvedilol: rationale and design of the OVERCOME trial. J Card Fail. 2011 Aug; 17(8):643-8. Epub 2011 May 6.
Cardinale D., Colombo A., Sandri M.T. et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition//Circulation. 2006 Dec 5; 114(23):2474-81. Epub 2006 Nov 13.
Cardinale D., Sandri M.T., Martinoni A. et al. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy//J Am Coll Cardiol. 2000 Aug; 36(2):517-22. Вестник Национального медико-хирургического Центра им. Н.И. Пирогова 2013, т. 8, № 4
Cardinale D., Sandri MT., Colombo A. et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy//Circulation. 2004 Jun 8; 109(22):2749-54. Epub 2004 May 17.
Cazin B., Gorin N.C., Laporte J.P. et al. Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations//Cancer. 1986 May 15;57(10):2061-9
Chung T., Lim W.C., Sy R. et al. Subacute cardiac toxicity following autologous haematopoietic stem cell transplantation in patients with normal cardiac function//Heart. 2008 Jul; 94(7):911-8. Epub 2007 Dec 10.
Dolci A., Dominici R., Cardinale D. et al. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use//Am J Clin Pathol. 2008 Nov; 130(5): 688-95.
Girinsky T., Cordova A., Rey A. et al. Thallium-201 scintigraphy is not predictive of late cardiac complications in patients with Hodgkin’s disease treated with mediastinal radiation. Int J Radiat Oncol Biol Phys2000; 48: 1503-1506.
Glanzmann C., Kaufmann P., Jenni R. et al. Cardiac risk after mediastinal irradiation for Hodgkin’s disease. Radiother Oncol1998; 46: 51-62.
Goldberg M.A., Antin J.H., Guinan E.C. et al. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor//Blood. 1986 Nov; 68(5):1114-8.
Gustavsson A., Eskilsson J., Landberg T. et al. Late cardiac effects after mantle radiotherapy in patients with Hodgkin’s disease. Ann 0ncol1990; 1: 355-363.
Herbay A., Dörken B., Mall G. et al. Cardiac damage in autologous bone marrow transplant patients: an autopsy study. Cardiotoxic pretreatment as a major risk factor//Klin Wochenschr. 1988 Dec 1; 66(23): 1175-81.
Hertenstein B., Stefanic M., Schmeiser T. et al. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant//J Clin Oncol. 1994 May; 12(5):998-1004.
Horacek J.M., Pudil R., Tichy M. et al. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia//Exp Oncol. 2007 Sep; 29(3):и243-7.
Katsurada K, Ichida M, Hozumi Y et al. High sensitive troponin T and peak early diastolic velocity of septal mitral annulus predict cardiac damage in breast cancer patients with adjuvant trastuzumab therapy//JACC., 2013; 61 (10): Е584.
Krishnan G.S., Chaudhary V., Al-Janadi A. et al. BCNU toxicity presenting with a large pericardial and pleural effusion//Ann Transplant. 2008; 13(1):44-7.
Kuittinen T., Husso-Saastamoinen M., Sipola P. et al. Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin’s lymphoma patients undergoing autologous stem cell transplantation//Bone Marrow Transplant. 2005 Dec; 36(12):1-077-82.
Kupari M., Volin L., Suokas A. et al. Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings//Bone Marrow Transplant. 1990 Feb; 5(2):91-8.
Masuko M., Ito M., Kurasaki T. et al. Plasma brain natriuretic peptide during myeloablative stem cell transplantation//Intern Med. 2007; 46(9):551-5. Epub 2007 May 1.
Melanson SE, Conrad MJ, Mosammaparast N et al. Implementation of a highly sensitive cardiac troponin I assay: test volumes, positivity rates and interpretation of results//Clin Chim Acta. 2008 Sep;395(1-2):57-61.
Munker R., Lazarus H. M., Atkinson K. The BMT Data Book, 2nd ed. Cambridge University Press, 2009, р. 237.
Murdych T., Weisdorf D.J. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997//Bone Marrow Transplant. 2001 Aug; 28(3):283-7.
Nagueh S.F., Sua H., Kopelen H.A. et al. Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler//J. Am. Coll. Cardiol. -2001. -Vol. 37. -P. 278-285.
Nousiainen T., Jantunen E., Vanninen E. et al. Acute neurohumoral and cardiovascular effects of idarubicin in leukemia patients. Eur J Haematol. 1998 Nov; 61(5):347-53.
Phillips G.L., Reece D.E. Clinical studies of autologous bone marrow transplantation in Hodgkin’s disease//Clin Haematol. 1986 Feb; 15(1):151-66.
Pihkala J., Saarinen U.M., Lundström U. et al. Effects of bone marrow transplantation on myocardial function in children//Bone Marrow Transplant. 1994 Feb;13(2-):149-55.
Roziakova L, Bojtarova E, Mistrik MJ et al. Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation//Exp Clin Cancer Res. 2012 Feb 9;31:13.
Salloum E., Jillella A.P., Nadkarni R. et al. Assessment of pulmonary and cardiac function after high dose chemotherapy with BEAM and peripheral blood progenitor cell transplantation//Cancer. 1998 Apr 15; 82(8):1506-12.
Snowden J.A., Hill G.R., Hunt P. et al. Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide. Bone Marrow Transplant. 2000 Aug; 26(3):309-13.
Styler M.J., Topolsky D.L., Crilley P.A. et al. Transient high grade heart block following autologous bone marrow infusion//Bone Marrow Transplant. 1992 Nov; 10(5):435-8.
Suzuki T., Hayashi D., Yamazaki T. et al. Elevated B-type natriuretic peptide levels after anthracycline administration//Am Heart J. 1998 Aug; 136(2):362-3.
Zver S., Zadnik V., Bunc M., et al. Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation//Int J Hematol. 2007 Jun; 85(5):408-14.
Zver S., Zadnik V., Cernelc P. et al. Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation//Int J Hematol. 2008 Sep; 88(2):227-36. Epub 2008 Jun 12.

Еще

Статья научная